Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Feb 1;18(1):56.
doi: 10.1186/s12891-017-1432-5.

Efficacy of paracetamol, diclofenac and advice for acute low back pain in general practice: design of a randomized controlled trial (PACE Plus)

M Schreijenberg  1 , P A J Luijsterburg  2 , Y D M Van Trier  2 , D Rizopoulos  3 , M A Koopmanschap  4 , L Voogt  5 , C G Maher  6 , B W Koes  2
Affiliations
Randomized Controlled Trial

Efficacy of paracetamol, diclofenac and advice for acute low back pain in general practice: design of a randomized controlled trial (PACE Plus)

M Schreijenberg et al. BMC Musculoskelet Disord. .

Abstract

Background: Low back pain is common and associated with a considerable burden to patients and society. There is uncertainty regarding the relative benefit of paracetamol and diclofenac and regarding the additional effect of pain medication compared with advice only in patients with acute low back pain. This trial will assess the effectiveness of paracetamol, diclofenac and placebo for acute low back pain over a period of 4 weeks. Furthermore, this trial will assess the additional effectiveness of paracetamol, diclofenac and placebo compared with advice only for acute low back pain over a period of 4 weeks.

Methods: The PACE Plus trial is a multi-center, placebo-blinded, superiority randomized controlled trial in primary care, with a follow-up of 12 weeks. Patients with acute low back pain aged 18-60 years presenting in general practice will be included. Patients are randomized into four groups: 1) Advice only (usual care conforming with the clinical guideline of the Dutch College of General Practitioners); 2) Advice and paracetamol; 3) Advice and diclofenac; 4) Advice and placebo. The primary outcome is low back pain intensity measured with a numerical rating scale (0-10). Secondary outcomes include compliance to treatment, disability, perceived recovery, costs, adverse reactions, satisfaction, sleep quality, co-interventions and adequacy of blinding. Between group differences for low back pain intensity will be evaluated using a repeated measurements analysis with linear effects models. An economic evaluation will be performed using a cost-effectiveness analysis with low back pain intensity and a cost-utility analysis with quality of life. Explorative analyses will be performed to assess effect modification by predefined variables. Ethical approval has been granted. Trial results will be released to an appropriate peer-viewed journal.

Discussion: This paper presents the design of the PACE Plus trial: a multi-center, placebo-blinded, superiority randomized controlled trial in primary care that will assess the effectiveness of advice only, paracetamol, diclofenac and placebo for acute low back pain.

Trial registration: Dutch Trial Registration NTR6089 , registered September 14th, 2016.

Protocol: Version 4, June 2016.

Keywords: Acetaminophen; Analgesics; Anti-inflammatory agents; Clinical trial; Diclofenac; General practice; General practitioners; Low back pain; Non-steroidal; Pain; Randomized controlled trial; Therapy.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flow-chart of the PACE Plus trial
See this image and copyright information in PMC

References

    1. Global Burden of Disease Study C Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;386(9995):743–800. doi: 10.1016/S0140-6736(15)60692-4. - DOI - PMC - PubMed
    1. Lambeek LC, van Tulder MW, Swinkels IC, Koppes LL, Anema JR, van Mechelen W. The trend in total cost of back pain in the Netherlands in the period 2002 to 2007. Spine. 2011;36(13):1050–1058. doi: 10.1097/BRS.0b013e3181e70488. - DOI - PubMed
    1. Deyo RA. Low-back pain. Sci Am. 1998;279(2):48–53. doi: 10.1038/scientificamerican0898-48. - DOI - PubMed
    1. Koes BW, van Tulder M, Lin CW, Macedo LG, McAuley J, Maher C. An updated overview of clinical guidelines for the management of non-specific low back pain in primary care. Eur Spine J. 2010;19(12):2075–2094. doi: 10.1007/s00586-010-1502-y. - DOI - PMC - PubMed
    1. Chavannes AW, Mens JMA, Koes BW, Lubbers WJ, Ostelo R, Spinnewijn WEM, Kolnaar BGM. NHG-guideline Non-specific low back pain (in Dutch) Huisarts Wet. 2005;48(3):113–123.

Publication types

MeSH terms

Associated data